Streetbeat News

Revenues

MQ

Levi & Korsinsky has initiated an investigation into Marqeta, Inc. for potential violations of federal securities laws after the company reduced its revenue growth forecast for Q4.

Portfolio Pulse from

November 07, 2024 | 4:45 pm

ADTN

ADTRAN reported a wider-than-expected loss for Q3 2024, attributed to lower revenues and soft demand in its Network Solutions business.

Portfolio Pulse from

November 07, 2024 | 4:45 pm

PN

Skycorp Solar Group is planning a U.S. IPO to raise $12.15 million, despite having shaky revenue and low margins. The company targets the solar PV and high-performance computing markets but faces risks such as unpredictable Chinese regulations and potential high post-IPO volatility.

Portfolio Pulse from

November 07, 2024 | 4:45 pm

COTY

COTY's Q1 earnings and sales were below expectations due to ongoing struggles in the Chinese mainland, Asia Travel Retail, and the U.S. mass cosmetics market, despite overall higher sales and earnings.

Portfolio Pulse from

November 07, 2024 | 4:45 pm

ENS

Enersys reported its fiscal Q2 earnings, which surpassed estimates despite a 1.9% decline in net sales. The decline was primarily due to the underperformance of the Energy Systems segment.

Portfolio Pulse from

November 07, 2024 | 4:45 pm

PCRX

Pacira Biosciences (PCRX) reported mixed Q3 2024 results with earnings surpassing estimates but revenues falling short. Despite this, Exparel sales showed year-over-year growth.

Portfolio Pulse from

November 07, 2024 | 4:30 pm

PLNT

Planet Fitness, Inc. has reported strong Q3 growth with a 5.3% increase in revenues and adjusted EBITDA of $123.1 million. Despite slower equipment sales, the franchise and subscription model remains robust, with 21 new stores opened. Concerns about debt persist, but increased guidance has triggered a stock rally.

Portfolio Pulse from

November 07, 2024 | 4:30 pm

PCG

PG&E's Q3 earnings exceeded expectations with total revenues of $5.94 billion, marking a 0.9% increase year-over-year. However, operating revenues fell short of the Zacks Consensus Estimate by 10.9%.

Portfolio Pulse from

November 07, 2024 | 4:30 pm

SRDX

Surmodics (SRDX) reported its fiscal fourth-quarter results, showing growth in the medical device segment. The company's earnings and revenues surpassed the Zacks Consensus Estimate, although margins were down.

Portfolio Pulse from

November 07, 2024 | 4:30 pm

TDG

TransDigm Group's Q4 net sales increased by 18% year-over-year to $2.19 billion, surpassing the Zacks Consensus Estimate by 1.1%.

Portfolio Pulse from

November 07, 2024 | 4:30 pm